6640--Immucor Bloodbank Reagents
ID: 36C24625Q0087Type: Special Notice
Overview

Buyer

VETERANS AFFAIRS, DEPARTMENT OFVETERANS AFFAIRS, DEPARTMENT OF246-NETWORK CONTRACTING OFFICE 6 (36C246)HAMPTON, VA, 23667, USA

NAICS

In-Vitro Diagnostic Substance Manufacturing (325413)

PSC

LABORATORY EQUIPMENT AND SUPPLIES (6640)

Original Source

https://sam.gov/opp/fe53a8d11c074475ac5f58af5a3a5dfe/view
Timeline
    Description

    The Department of Veterans Affairs, specifically the Network Contracting Office 6, is seeking to negotiate a sole source Firm-Fixed Price contract for the procurement of Blood Bank Reagents from Immucor, Inc. This requirement is specifically for the Pathology Department at the Asheville VA Medical Center, necessitated by the need for compatible reagents for the Echo Lumena Blood Bank Analyzer, which is critical for daily operations. The government has determined that Immucor is the only responsible source capable of providing these specialized items without unacceptable delays or additional costs. Interested firms must express their capabilities to the contract specialist, Daleta S. Coles, via email by October 14, 2024, as this announcement serves informational purposes only and does not constitute a solicitation for competitive proposals.

    Point(s) of Contact
    Daleta S ColesContract Specialist
    757-722-9961 ext-3115
    Daleta.Coles@va.gov
    Files
    Title
    Posted
    36C24625Q0087.docx
    The Department of Veterans Affairs (VA) is issuing a special notice regarding a sole source contract for purchasing Blood Bank Reagents from Immucor, Inc. This procurement is intended for the Pathology Department at the Asheville VA Medical Center and arises from the specific need for compatible reagents for the Echo Lumena Blood Bank Analyzer utilized in its operations. The contract will be awarded as a Firm-Fixed Price, effective October 1, 2019. No competitive offers will be solicited due to the unique nature of the supplies, as research indicates that Immucor is the only responsible source eligible to fulfill the requirements without unreasonable delays or additional costs. Interested firms must express their capabilities within three days of the notice and provide details on their business classification. This announcement serves informational purposes only and does not obligate the government to procure the mentioned products or services. Inquiries must be directed to the specified contract specialist via email, with the deadline for response set for October 14, 2024.
    Lifecycle
    Title
    Type
    6640--Immucor Bloodbank Reagents
    Currently viewing
    Special Notice
    Similar Opportunities
    6640--06 BACT/ALERT VIRTUO Blood Culture System, Consumables, and Support
    Active
    Veterans Affairs, Department Of
    The Department of Veterans Affairs is seeking to establish a sole-source Indefinite Delivery Indefinite Quantity (IDIQ) contract for the BACT/ALERT VIRTUO Blood Culture System, including necessary consumables and support services, to be utilized across multiple laboratories within VISN 6. This procurement aims to ensure the provision of a fully automated blood culture testing system, which is critical for healthcare services provided to veterans, with the contract expected to commence on November 29, 2024. The decision to pursue a sole-source contract with BioMerieux Incorporated follows market research indicating that these specialized items are exclusively available from the original equipment manufacturer, thereby avoiding delays and additional costs. Interested parties may express their capabilities to Contract Specialist Stephanie McElmore via email by November 19, 2024, and should clearly indicate their business status regarding size and ownership.
    6640--6-Month Bridge - CPT Consumables/Reagents Protein Electrophoresis Analyzer, Ann Arbor
    Active
    Veterans Affairs, Department Of
    The Department of Veterans Affairs intends to negotiate a sole-source contract for protein electrophoresis consumables and reagents specifically for the Helena Laboratories Automated Agarose Gel Electrophoresis Analyzer. The procurement is necessary as the reagents and consumables provided by Helena Laboratories are uniquely compatible with their system, ensuring accurate test results, while alternatives could compromise the integrity of the tests. This contract, designated as 36C25025Q0192, will be awarded under a firm fixed-price arrangement, with responses due by December 19, 2024. Interested parties may contact James Howard at James.Howard3@va.gov for further information regarding this opportunity.
    In Vitro Biological Reagents
    Active
    Health And Human Services, Department Of
    The National Institutes of Health (NIH), specifically the National Institute of Allergy and Infectious Diseases (NIAID), intends to negotiate a sole source procurement with Becton, Dickinson and Company for various in vitro biological reagents essential for research purposes. The procurement includes specific quantities of antibodies and reagents, such as Hu CD183 BV711 and Hu IL-13 BV421, along with shipping and handling to be delivered to Gaithersburg, Maryland. This procurement is justified under the authority of 41 U.S.C. 1901 (a)(1), indicating that only one responsible source can meet the agency's requirements. Interested parties may submit a capability statement via the NIAID electronic Simplified Acquisition Submission System (eSASS) by December 30, 2024, with all submissions considered at the Government's discretion. For further inquiries, contact Leah Hinson at leah.hinson@nih.gov.
    6630--V16 Lab Chemistry and Immunochemistry CPRR BPA (VA-25-00010416)
    Active
    Veterans Affairs, Department Of
    The Department of Veterans Affairs (VA) is preparing to issue a Request for Quotation (RFQ) for a Blanket Purchase Agreement (BPA) focused on Chemistry and Immunochemistry instrumentation and testing for the South Central VA Health Care Network (VISN 16). This procurement aims to standardize automated equipment across 8 medical center and 20 outpatient laboratories, ensuring compliance with the 1988 Clinical Laboratory Improvement Act and FDA approval for all reagents, while also providing operator training and 24/7 repair services. The initiative underscores the VA's commitment to enhancing laboratory capabilities through modern technology, with site visits permitted until February 28, 2025, allowing vendors to assess laboratory conditions and align their offerings with specific site requirements. Interested contractors can contact Diyonne Williams, the Contracting Officer, at Diyonne.Williams@va.gov for further information.
    Molecular HIV-PCR Test Equipment Maintenance
    Active
    Veterans Affairs, Department Of
    The Department of Veterans Affairs intends to award a sole source contract for the maintenance of Molecular HIV-PCR Test Equipment, specifically targeting Roche Diagnostics Corp. This procurement involves the provision of microbiology molecular diagnostics reagents and analyzer rental, including the Roche 6800 and Cobas Prime pre-analytical instruments, along with maintenance and emergency services for the equipment. The contract is crucial for supporting analytical services related to various infectious diseases, including HIV and COVID-19, and is expected to be finalized by February 2, 2025. Interested parties must submit evidence of capability by December 26, 2024, to Alecia Mitchell at alecia.mitchell@va.gov, as the government retains discretion on whether to compete the procurement.
    6640--VISN Blanket Purchase Agreement NEW Coagulation CPRR
    Active
    Veterans Affairs, Department Of
    The Department of Veterans Affairs (VA) is seeking proposals for a Blanket Purchase Agreement (BPA) to acquire coagulation analyzers, related equipment, reagents, and services for various VA medical facilities. The procurement aims to ensure the availability of high-quality coagulation testing capabilities, which are critical for patient diagnosis and treatment, over a five-year term from February 1, 2025, to January 31, 2030. This opportunity emphasizes compliance with federal guidelines, including cybersecurity measures for medical devices, and prioritizes service-disabled veteran-owned businesses. Interested vendors must submit their proposals by January 6, 2025, and can contact Contracting Specialist Lindsey M Zwaagstra at Lindsey.Zwaagstra@va.gov for further information.
    J065--Intent to Sole Source Cepheid Lab Analyzers Service
    Active
    Veterans Affairs, Department Of
    The Department of Veterans Affairs (VA) intends to award a sole source contract to Cepheid for the maintenance and support of laboratory analyzers within the Veterans Integrated Service Network 23 (VISN 23). This contract will cover all labor, parts, travel expenses, and ensure a 98% uptime guarantee for the Xpert devices, along with annual preventative maintenance checks and software upgrades. The services are critical for maintaining operational efficiency and reliability in medical equipment support within government healthcare settings. Interested vendors who believe they can meet the requirements are encouraged to submit capability statements by December 27, 2024, to Contract Specialist Jennifer Watkins-Schoenig at Jennifer.watkins-schoenig@VA.gov.
    J065--Abbott Point of Care Contract FY25
    Active
    Veterans Affairs, Department Of
    The Department of Veterans Affairs, specifically the Veterans Health Administration's Network Contracting Office 20, intends to award a sole-source contract to Abbott Point of Care for maintenance and support services for the i-STAT system at the Mann-Grandstaff VA Medical Center in Spokane, WA. The contract will be a firm fixed price and is necessitated by the proprietary nature of the i-STAT system, which can only be serviced by its manufacturer, Abbott Laboratories, in accordance with Federal Acquisition Regulation guidelines. This procurement underscores the VA's commitment to maintaining high-quality service for specialized medical equipment essential for patient care. Interested parties must submit letters of interest and qualifications to Contract Specialist Tracy Heath at tracy.heath@va.gov by January 3, 2025, to be considered for this opportunity.
    6515--Intent to Sole Source - PENUMBRA SURGICAL CATHETERS
    Active
    Veterans Affairs, Department Of
    The Department of Veterans Affairs intends to award a sole source contract to USVetServ, LLC for the supply of Penumbra Surgical Catheters to the Margaret Cochran Corbin VA Medical Center. This procurement specifically seeks brand-name medical supplies categorized under NAICS code 339113, with an estimated delivery timeframe of 30 days following the contract award. The Penumbra Surgical Catheters are critical for medical procedures requiring specialized thrombectomy equipment. Interested parties may express their interest and capabilities to provide similar services by submitting detailed information to the contracting officer, Mohammed Hussain, at Mohammed.Hussain2@va.gov, by 3:00 PM PST on December 26, 2024. This notice is not a request for proposals or quotations, and the government retains discretion on whether to open the procurement for competition based on the responses received.
    Q301 | NOI Heart and Kidney Transplant Rejection testing
    Active
    Veterans Affairs, Department Of
    The Department of Veterans Affairs (VA) intends to negotiate a Sole Source Award with CareDX, Inc. for heart and kidney transplant rejection testing, as outlined in their Special Notice. The VA Palo Alto Health Care System (VAPAHCS) requires specific post-transplant testing services that only CareDX can provide, including Allosure Kidney and AlloMap Heart blood tests, which are crucial for monitoring transplant rejection and minimizing the need for invasive biopsies. This initiative underscores the VA's commitment to enhancing patient care for veterans while adhering to health regulations and standards. Interested parties may direct inquiries to Gary Christensen at gary.christensen@va.gov, as this notice is not a formal solicitation and no proposals will be accepted unless compelling evidence for competition is presented.